Advertisement

Topics

Takeda reveals collaboration aimed at bolstering oncology pipeline

05:42 EDT 8 Aug 2017 | Pharmafile

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move to prepare for this after signing a licensing collaboration with Molecular Templates.

The research and licensing collaboration sees Takeda gain access to potential therapeutic targets developed through the application of Molecular Templates’ engineered toxin bodies technology platform.

read more

Original Article: Takeda reveals collaboration aimed at bolstering oncology pipeline

NEXT ARTICLE

More From BioPortfolio on "Takeda reveals collaboration aimed at bolstering oncology pipeline"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...